Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Endocrinology Associates Inc
mi
from
Columbus, OH
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Endocrinology Associates Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Ohio State University
mi
from
Columbus, OH
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Pediatric Endocrinology, Genetics & Metabolism
mi
from
Oklahoma City, OK
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Pediatric Endocrinology, Genetics & Metabolism
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Rapid City Regional Hospital/Health Clinical Research
mi
from
Rapid City, SD
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Rapid City Regional Hospital/Health Clinical Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Research Institute of Dallas
mi
from
Dallas, TX
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Research Institute of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Northeast Clinical Research of San Antonio LLC
mi
from
San Antonio, TX
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Northeast Clinical Research of San Antonio LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center
mi
from
San Antonio, TX
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Consano Clinical Research, LLC
mi
from
San Antonio, TX
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Consano Clinical Research, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated:  12/31/1969
Children's Hospitals and Clinics - Minnesota
mi
from
Saint Paul, MN
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Children's Hospitals and Clinics - Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Comparative Effects of Antidiabetic Medications on Postprandial Hyperlipidemia, Free Fatty Acid Signaling, and Endothelial Dysfunction in Individuals With Prediabetes
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Comparative Effects of Antidiabetic Medications on Postprandial Hyperlipidemia, Free Fatty Acid Signaling, and Endothelial Dysfunction in Individuals With Prediabetes
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Advancing Diabetes Management in Adolescents Using Health Information Technology
Advancing Diabetes Management in Adolescents Using Health Information Technology
Status: Enrolling
Updated:  12/31/1969
Riley Children's Specialties
mi
from
Carmel, IN
Advancing Diabetes Management in Adolescents Using Health Information Technology
Advancing Diabetes Management in Adolescents Using Health Information Technology
Status: Enrolling
Updated: 12/31/1969
Riley Children's Specialties
mi
from
Carmel, IN
Click here to add this to my saved trials
Advancing Diabetes Management in Adolescents Using Health Information Technology
Advancing Diabetes Management in Adolescents Using Health Information Technology
Status: Enrolling
Updated:  12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Advancing Diabetes Management in Adolescents Using Health Information Technology
Advancing Diabetes Management in Adolescents Using Health Information Technology
Status: Enrolling
Updated: 12/31/1969
Riley Children's Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Alliance Research Centers /ID# 125945
mi
from
Laguna Hills, CA
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Alliance Research Centers /ID# 125945
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Frank Clark Urology Center /ID# 147794
mi
from
Santa Monica, CA
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Frank Clark Urology Center /ID# 147794
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Research by Design, LLC /ID# 160784
mi
from
Evergreen Park, IL
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Research by Design, LLC /ID# 160784
mi
from
Evergreen Park, IL
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Southern IL Univ School of Med /ID# 129010
mi
from
Springfield, IL
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Southern IL Univ School of Med /ID# 129010
mi
from
Springfield, IL
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Crescent City Clinical Res Ctr /ID# 150989
mi
from
Metairie, LA
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Crescent City Clinical Res Ctr /ID# 150989
mi
from
Metairie, LA
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Tulane Univ /ID# 130308
mi
from
New Orleans, LA
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Tulane Univ /ID# 130308
mi
from
New Orleans, LA
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Albany Medical College /ID# 131068
mi
from
Albany, NY
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Albany Medical College /ID# 131068
mi
from
Albany, NY
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Urologic Consultants of Southeastern Pennsylvania /ID# 124277
mi
from
Bala-Cynwyd, PA
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Urologic Consultants of Southeastern Pennsylvania /ID# 124277
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Eastern Virginia Medical School /ID# 153740
mi
from
Norfolk, VA
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Eastern Virginia Medical School /ID# 153740
mi
from
Norfolk, VA
Click here to add this to my saved trials
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated:  12/31/1969
Charite Research Organisation GmbH /ID# 154264
mi
from
Berlin,
Atrasentan Spermatogenesis and Testicular Function
A Multicenter, Single-Arm Study of the Effects of Atrasentan on Spermatogenesis and Testicular Function
Status: Enrolling
Updated: 12/31/1969
Charite Research Organisation GmbH /ID# 154264
mi
from
Berlin,
Click here to add this to my saved trials
Vascular Reparative Mechanism in Diabetes
Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
Vascular Reparative Mechanism in Diabetes
Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Park Nicollet Clinic - International Diabetes Center
mi
from
Minneapolis, MN
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Park Nicollet Clinic - International Diabetes Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Sutter Institute for Medical Research Excellence in Diabetes and Endocrinology
mi
from
Sacramento, CA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Sutter Institute for Medical Research Excellence in Diabetes and Endocrinology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
The Pediatric and Endocrine Diabetes Specialists
mi
from
Las Vegas, NV
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
The Pediatric and Endocrine Diabetes Specialists
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Colorado Health Science Center, Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health Science Center, Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Madison Clinic for Pediatric Diabetes at UCSF
mi
from
San Francisco, CA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Madison Clinic for Pediatric Diabetes at UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
SoCal Diabetes
mi
from
Torrance, CA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
SoCal Diabetes
mi
from
Torrance, CA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Nemours Children's Health System
mi
from
Jacksonville, FL
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Nemours Children's Health System
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
University of Minnesota Pediatric Endocrinology Clinic
mi
from
Minneapolis, MN
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
University of Minnesota Pediatric Endocrinology Clinic
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Stony Brook Children's Hospital
mi
from
East Setauket, NY
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Stony Brook Children's Hospital
mi
from
East Setauket, NY
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Texas Children Hospital/Baylor College of Medicine
mi
from
Houston, TX
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Texas Children Hospital/Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital and Clinics of Minnesota
mi
from
Saint Paul, MN
Threshold Suspend in Pediatrics at Home
Multi-Center, Prospective, Observational Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System in Pediatric Patients With Type 1 Diabetes
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital and Clinics of Minnesota
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Status: Enrolling
Updated:  12/31/1969
Wills Eye Hospital
mi
from
Philadelphia, PA
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Collaborative Care for Depression and Diabetic Retinopathy in African Americans
Status: Enrolling
Updated: 12/31/1969
Wills Eye Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hawaii Patient Reward And Incentives to Support Empowerment
A Randomized Incentive-Based Diabetes Self-Management Study (Hawaii Patient Reward And Incentives to Support Empowerment Project)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Hawaii
mi
from
Honolulu, HI
Hawaii Patient Reward And Incentives to Support Empowerment
A Randomized Incentive-Based Diabetes Self-Management Study (Hawaii Patient Reward And Incentives to Support Empowerment Project)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Latinos Combating Diabetes
Latinos Combatiendo la Diabetes (Latinos Combating Diabetes)
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Latinos Combating Diabetes
Latinos Combatiendo la Diabetes (Latinos Combating Diabetes)
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Tucson, AZ
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status: Enrolling
Updated:  12/31/1969
Novo Nordisk Investigational Site
mi
from
Jacksonville, FL
A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
A 26-week Open Label, Randomised, 2-armed, Parallel Group, Multi-centre Trial Investigating Efficacy and Safety of Insulin Detemir Versus Insulin Neutral Protamine Hagedorn in Combination With the Maximum Tolerated Dose of Metformin and Diet/Exercise on Glycaemic Control in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on the Maximum Tolerated Dose of Metformin ± Other Oral Antidiabetic Drug(s) ± Basal Insulin
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials